Glycaemic, Blood Pressure and Cholesterol Control in 25 629 Diabetics

Overview

Journal Cardiovasc J Afr

Specialty Cardiology & Vascular Diseases

Date 2015 Sep 26

PMID 26407221

Citations 11

Authors

Y Pinchevsky

N Butkow

T Chirwa

F J Raal

Affiliations

Soon will be listed here.

Abstract

Objective: To examine and compare the extent to which people with type 2 diabetes (T2DM) are achieving haemoglobin A1c (HbA1c), blood pressure (BP) and LDL cholesterol (LDL-C) treatment targets.

Methods: A review of databases (MEDLINE Ovid, Pubmed and Sabinet) was performed and limited to the following terms: type 2 diabetes mellitus AND guideline AND goal achievement for the years 2009 to 2014 (five years).

Results: A total of 14 studies (25 629 patients) were selected across 19 different countries. An HbA1c level of 7.0% (or less) was achieved by 44.5% of subjects (range 19.2-70.5%), while 35.2% (range 7.4-66.3%) achieved BP of 130/80 mmHg (or less), and 51.4% (range 20.0-82.9%) had an LDL-C level of either 2.5 or 2.6 mmol/l (100 mg/dl or less).

Conclusion: Despite guideline recommendations that lowering of HbA1c, BP and lipids to target levels in T2DM will lead to a reduction in morbidity and mortality rates, we found that control of these risk factors remains suboptimal, even across different settings.

Citing Articles

Changes in trends and patterns of glycaemic control at Ghana's National Diabetes Management and Research Centre during the era of the COVID-19 pandemic.

Swaray S, Tetteh J, Djonor S, Ekem-Ferguson G, Clottey R, Yacoba A PLOS Glob Public Health. 2023; 3(6):e0002024.

PMID: 37315063 PMC: 10266607. DOI: 10.1371/journal.pgph.0002024.

Suboptimal blood pressure control and its associated factors among people living with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis.

Akalu Y, Yeshaw Y, Tesema G, Tiruneh S, Teshale A, Angaw D Syst Rev. 2022; 11(1):220.

PMID: 36243876 PMC: 9569048. DOI: 10.1186/s13643-022-02090-4.

The Translation and Commercialisation of Biomarkers for Cardiovascular Disease-A Review.

Saleh S, George J, Kott K, Meikle P, Figtree G Front Cardiovasc Med. 2022; 9:897106.

PMID: 35722087 PMC: 9201254. DOI: 10.3389/fcvm.2022.897106.

Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.

Midthassel T, Hansen A PLoS One. 2021; 16(12):e0261471.

PMID: 34972136 PMC: 8719672. DOI: 10.1371/journal.pone.0261471.

Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.

Spencer S, Chung J, Belongia E, Sundaram M, Meece J, Coleman L Influenza Other Respir Viruses. 2021; 16(3):562-567.

PMID: 34859584 PMC: 8983908. DOI: 10.1111/irv.12933.

References

Al-Taweel D, Awad A, Johnson B . Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait. Int J Clin Pharm. 2012; 35(2):244-50. DOI: 10.1007/s11096-012-9738-8. View

McLean D, Simpson S, McAlister F, Tsuyuki R . Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol. 2006; 22(10):855-60. PMC: 2569016. DOI: 10.1016/s0828-282x(06)70304-x. View

Stone M, Charpentier G, Doggen K, Kuss O, Lindblad U, Kellner C . Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care. 2013; 36(9):2628-38. PMC: 3747883. DOI: 10.2337/dc12-1759. View

Colhoun H, Betteridge D, Durrington P, Hitman G, Neil H, Livingstone S . Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004; 364(9435):685-96. DOI: 10.1016/S0140-6736(04)16895-5. View

Hayat S, Patel B, Khattar R, Malik R . Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004; 107(6):539-57. DOI: 10.1042/CS20040057. View

Casagrande S, Fradkin J, Saydah S, Rust K, Cowie C . The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013; 36(8):2271-9. PMC: 3714503. DOI: 10.2337/dc12-2258. View

Nobels F, Debacker N, Brotons C, Elisaf M, Hermans M, Michel G . Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus. Cardiovasc Diabetol. 2011; 10:82. PMC: 3189404. DOI: 10.1186/1475-2840-10-82. View

Motala A . Diabetes trends in Africa. Diabetes Metab Res Rev. 2002; 18 Suppl 3:S14-20. DOI: 10.1002/dmrr.284. View

Juni P, Holenstein F, Sterne J, Bartlett C, Egger M . Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol. 2002; 31(1):115-23. DOI: 10.1093/ije/31.1.115. View

10.

Sease J, Franklin M, Gerrald K . Pharmacist management of patients with diabetes mellitus enrolled in a rural free clinic. Am J Health Syst Pharm. 2012; 70(1):43-7. DOI: 10.2146/ajhp120221. View

11.

Hermans M, Elisaf M, Michel G, Muls E, Nobels F, Vandenberghe H . Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial. Diabetes Care. 2013; 36(11):3388-95. PMC: 3816864. DOI: 10.2337/dc12-1853. View

12.

. Standards of medical care in diabetes--2011. Diabetes Care. 2011; 34 Suppl 1:S11-61. PMC: 3006050. DOI: 10.2337/dc11-S011. View

13.

Webb E, Rheeder P, Van Zyl D . Diabetes care and complications in primary care in the Tshwane district of South Africa. Prim Care Diabetes. 2014; 9(2):147-54. DOI: 10.1016/j.pcd.2014.05.002. View

14.

Kibirige D, Atuhe D, Sebunya R, Mwebaze R . Suboptimal glycaemic and blood pressure control and screening for diabetic complications in adult ambulatory diabetic patients in Uganda: a retrospective study from a developing country. J Diabetes Metab Disord. 2014; 13(1):40. PMC: 3974012. DOI: 10.1186/2251-6581-13-40. View

15.

Morren J, Baboolal N, Davis G, McRae A . Assessment of treatment goals attained by patients according to guidelines for diabetes management in primary care centres in North Trinidad. Qual Prim Care. 2010; 18(5):335-43. View

16.

Hall V, Thomsen R, Henriksen O, Lohse N . Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011; 11:564. PMC: 3156766. DOI: 10.1186/1471-2458-11-564. View

17.

Goderis G, Borgermans L, Heyrman J, Van Den Broeke C, Grol R, Boland B . Type 2 diabetes in primary care in belgium: need for structured shared care. Exp Clin Endocrinol Diabetes. 2009; 117(8):367-72. DOI: 10.1055/s-0028-1103286. View

18.

. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998; 317(7160):703-13. PMC: 28659. View

19.

Braga M, Casanova A, Teoh H, Gerstein H, Fitchett D, Honos G . Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study. Int J Clin Pract. 2012; 66(5):457-64. DOI: 10.1111/j.1742-1241.2012.02894.x. View

20.

Umar-Kamara M, Tufts K . Impact of a quality improvement intervention on provider adherence to recommended standards of care for adults with type 2 diabetes mellitus. J Am Assoc Nurse Pract. 2013; 25(10):527-534. DOI: 10.1111/1745-7599.12018. View